The physicians' role in the clinical development of new medicines
| Autor: | S. J. Warrington, S. I. Ankier |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
medicine.medical_specialty
Pathology Clinical Trials as Topic Informed Consent business.industry Medical record Alternative medicine Role General Medicine Medical Records Clinical trial Informed consent Fees and Charges New chemical entity Family medicine General practice Medicine Drug Evaluation Humans Ethics Medical business Physician's Role Research Article |
| Zdroj: | Postgraduate medical journal. 66(771) |
| ISSN: | 0032-5473 |
| Popis: | At one time the process of testing new medicines was the province mainly of physicians in teaching hospitals, but this is no longer so: physicians in district hospitals and in general practice are increasingly involved because they are caring for the patients eligible for the clinical trials. In this article we review briefly the early stages in the development of a new drug, or 'new chemical entity' (NCE), and consider especially those aspects which are important to the physician participating in that process. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|